Cochlear reported $1.7B in Equity Capital and Reserves for its first fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Ansell ANN:AU $ 1.55B 60.4M
Australian Pharma API:AU $ 438.81M 21.59M
Cochlear COH:AU $ 1.7B 60.3M
CSL CSL:AU $ 8.38B 227M
Estia Health EHE:AU $ 615.73M 11.67M
Fisher Paykel Healthcare FPH:NZ 1.59B 69.9M
Healius Ltd HLS:AU $ 1.86B 149.4M
Integral Diagnostics Ltd IDX:AU 254.74M 1.34M
Japara Healthcare JHC:AU 210.82M 3.21M
Mayne Pharma MYX:AU $ 768.36M 2.76M
Monash IVF Group Ltd MVF:AU 266.68M 2.53M
Nanosonics Ltd NAN:AU $ 135.57M 5.22M
Opthea Ltd OPT:AU 135.29M 62.3M
Polynovo Ltd PNV:AU 22.35M 333.52K
Ramsay Health Care RHC:AU $ 4.03B 107.2M
Regis Healthcare REG:AU 141.96M 16.51M
ResMed RMD:AU $ 2.89B 176.44M
Sigma Healthcare Ltd SIG:AU 503.27M 30.95M
Somnomed Ltd SOM:AU 32.16M 1.47M
Sonic Healthcare SHL:AU $ 6.38B 555.65M
Telix Pharmaceuticals Ltd TLX:AU 47.93M 31.09M
Virtus Health VRT:AU 299.09M 3.61M